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Abstract
Purpose. This paper describes the functional and oncologic outcome of 30 cases (in 29 patients) treated with limb-salvage
surgery for localized soft tissue sarcoma (STS) or ® bromatosis of the foot and ankle.
Subjects. Patients were eligible for the study if they had a STS or ® bromatosis in the distal one-third of the tibia or the
foot such that ablative surgery would require a below-knee amputation; had no metastatic disease at presentation; and had
a minimum of 2 years of follow-up.
Methods. Function was prospectively evaluated using the modi® ed Enneking functional rating scale (MSTS) at 3, 6, 12
months and at most recent follow-up. Premorbid work status and change following surgery, lower leg oedema, and the
use of orthotics and ambulatory aids were consecutively assessed. Tumour characteristics were recorded and patients were
followed for systemic and local recurrence.
Results. Thirty-six consecutive cases were managed by a multi-disciplinary sarcoma team. Six patients underwent
below-knee amputation due to extensive local disease, while 30 cases were treated with limb-salvage surgery. Of the
patients treated with limb salvage, there were 19 high-grade sarcomas, ® ve low-grade sarcomas and six cases of
® bromatosis. Microscopically negative margins were achieved in 26 of 30 cases. Ten cases required bone excision, and
eight patients needed free vascularized tissue ¯ aps. Twenty-® ve patients received adjuvant radiotherapy. Seven patients
had post-operative complications. At mean follow-up of 52 months (range 24± 109 months), four patients had developed
systemic recurrence. There was one local recurrence in a patient with ® bromatosis, while another patient with ® bromatosis
developed recurrence a considerable distance from the surgical and radiation ® eld. Mean scores on the MSTS were 27.5
(range 11± 35), 29.9 (range 13± 35), 31.4 (range 17± 35) and 31.0 (range 13± 35) at 3, 6, 12 months and at most recent
follow-up, respectively. Eighty-® ve per cent of the patients scored good to excellent at their last visit. Twelve patients
reported persistent pain with two continuing to require occasional narcotics. Six had persistent mild oedema. Four
required shoe modi® cations and three continue to use a cane. Six patients were unable to return to their premorbid
employment with the majority of these previously employed in jobs requiring physical labour or long periods of either
standing or walking.
Discussion. Thirty of 36 patients (83%) presenting with foot and ankle STS or ® bromatosis were candidates for limb
preservation. With excellent local control and good functional outcome demonstrated in this study, limb salvage should
be a primary goal in the management of selected patients with STS and ® bromatosis of the foot and ankle.
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Introduction
The treatment of soft tissue sarcoma (STS) in the
extremity has changed markedly in the past 30
years. Historically, surgical excision by amputation
was the mainstay of management of STS of the
extremities. Subsequently, Simon and Enneking
showed that achieving local control at the primary
site by surgical means alone required radical local
resection or amputation.
1 Although improvements
in local recurrence rates were observed with radical
surgery, the extent of resection often dramatically
altered limb function. More recently, advances in
radiological imaging and the addition of irradiation
as adjuvant therapy following local excision have
resulted in acceptable rates of both local recurrence
and extremity function.
2± 9 Combined management
with irradiation and surgery has therefore become
the treatment of choice in resectable extremity
STS.
2± 6,9.
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Aggressive ® bromatosis is a non-encapsulated be-
nign mesenchymal neoplastic process that exhibits
local tumour spread and invasion without respect
for tissue planes. Both the disease and its treatment
can lead to signi® cant functional morbidity. Al-
though ® bromatosis does not metastasize, the inva-
siveness of this tumour is similar to the local
behaviour of STS
10± l2 and there is a high risk of
recurrence following surgical excision alone. The
optimal therapy for ® bromatosis is controversial and
treatment recommendations vary from a radical sur-
gical resection to observation. When eradication of
the ® bromatosis is warranted due to the functional
morbidity of the local disease, combined wide surgi-
cal excision and adjuvant radiotherapy offers the
best chance of success.
10± 12 In this situation, the
surgical management parallels that of extremity
STS.
The goal of achieving both complete surgical exci-
sion of a STS or ® bromatosis while maintaining
adequate limb function is particularly dif® cult in the
foot and ankle region. Soft tissue tumours of the
foot and ankle are rare and the majority of soft tissue
lesions in this location are benign, accounting for
the high rate of initial simple excision of unsuspec-
ted sarcomas and a delay in referral to a sarcoma
centre.
l3± l5 The weight-bearing demands of the distal
lower extremity, the limitations of soft tissue cover-
age and the complexity of underlying vital structures
are factors that complicate the planning of limb-
salvage surgery. While the literature emphasizes the
oncologic outcome in the management of tumours
of the foot, there is little information describing the
functional and psychological outcome, or the impact
of complications, following limb salvage of the foot
and ankle.
3,4,6,7,l6± 18. These functional issues are es-
pecially important in the management of foot and
ankle STS,
19± 20 since below-knee amputation and
prosthetic ® tting provides excellent function and
versatility in daily activities as well as the capacity to
engage in recreational activities.
21,22
The functional impact of limb-salvage surgery
versus amputation was ® rst addressed by Sugar-
baker.
20 Despite a variety of methodological prob-
lems with that study, it was apparent that both
oncological and functional outcome need to be
addressed to evaluate limb preservation in the man-
agement of soft tissue tumours. The purpose of this
study is to describe the management strategy that
we employed in a group of patients with localized
STS or ® bromatosis in the foot and ankle, and to
emphasize the functional status of the patients who
underwent limb salvage.
Subjects and methods
From 1987 to 1994, 36 consecutive cases meeting
the following inclusion criteria were managed by a
multi-disciplinary sarcoma group:
(1) histologically con® rmed STS or ® bromatosis
prior to de® nitive management;
(2) location of the lesion in the distal one-third of
the tibia or the foot such that ablative surgery
would require a below-knee amputation;
(3) no metastatic disease on pre-operative systemic
staging;
(4) minimum prospective follow-up of 24 months.
Patients with both de novo and locally recurrent
disease were included.
Initial patient work-up included chest radio-
graphy, chest computed tomography (CT), tech-
netium bone scan when indicated, plain ® lms of the
distal lower extremity, and axial imaging of the
lesion with either CT or magnetic resonance imag-
ing (MRI). Local staging of the extent of the disease
identi® ed patients eligible for limb-salvage surgery,
while cases that were deemed unresectable were
offered below-knee amputation. Criteria used to
assess resectability included clinical and radio-
logical assessment of tumour extent and invasion of
vital structures, previous surgical incisions and prior
management. All pathological diagnosis and assess-
ment of surgical margins were performed by experi-
enced musculoskeletal oncological pathologists. The
surgical margin was assessed using both the opera-
tive note and pathology report. Histological evi-
dence of disease at the inked surface of the specimen
was considered to be a positive margin.
2,3 The de-
cision for adjuvant chemotherapy or radiotherapy
was made by the multi-disciplinary team.
Adjuvant radiotherapy was administered using
either pre-operative or post-operative protocols.
Pre-operative treatment entailed 50 Gy in 25
fractions over 5 weeks. In the early period of the
study, most patients received a post-operative
boost of 16 Gy in eight fractions commencing after
wound healing. However, in the later stages the
boost was restricted to those cases in which the
margins of the resected specimen were microscopi-
cally positive at the time of surgery. A full course
of post-operative radiotherapy consisted of 66 Gy
in 33 fractions commencing after wound healing.
This technique has been described in previous
publications.
5,23
Of the 36 cases (in 35 patients) presenting with
STS or ® bromatosis in the distal one-third of
the leg or foot, four were unresectable and under-
went below-knee amputation. The remaining 32
cases were initially deemed appropriate for limb-
salvage surgery, but two patients were found at
the time of surgery to be unresectable with ade-
quate margins. Following further discussion, these
two patients were treated with below-knee ampu-
tation.
Data collected included: patient demographics
and symptoms; work status; pre-operative functional
status; neurovascular involvement; and tumour lo-
cation, size, histological type and grade. SarcomaLimb-salvage surgery 69
Table 1. The histological types of ankle and foot tumours. Thirty cases underwent limb salvage,
and six cases had below-knee amputation (shown in brackets)
Soft tissue sarcoma
Histological type High grade Low grade Fibromatosis
Malignant ® brous histiocytoma 7 (1) Ð Ð
Fibrosarcoma 2 2 Ð
Leiomyosarcoma 2 (1) Ð Ð
Clear cell sarcoma 2 (2) Ð Ð
Synovial cell sarcoma 1 (1) 1 Ð
Liposarcoma 1 1 Ð
Soft tissue chondrosarcoma Ð 1 (1) Ð
Neurosarcoma 1 Ð Ð
Epitheliod sarcoma 1 Ð Ð
Rhabdomyosarcoma 1 Ð Ð
STSÐ unclassi® ed 1 Ð Ð
Aggressive ® bromatosis Ð Ð 6
Total 30 1 (6)5 36 19 (5) 5 (1) 6
histological grade was designated as low- or high-
grade malignancy
24 to allow consistency for com-
parison between other studies.
2,3,7. Chemotherapy
and radiotherapy treatment and surgical procedures
and reconstruction characteristics were recorded.
Oncologic outcome with respect to local and sys-
temic recurrence, as well as survival, were docu-
mented.
The 30 cases (in 29 patients) treated with limb
preservation were followed prospectively and func-
tional outcome was documented by a single physio-
therapist at 3, 6, 12 months post-operatively, and at
most recent visit to evaluate symptoms, work status,
oedema,
25 use of walking aids and the parameters
necessary to score the modi® ed Musculoskeletal
Tumour Society (MSTS) functional rating scale.
26.
The maximum score is 35 and the seven items
included are: pain, range of motion, strength, stabil-
ity, deformity, functional activity and emotional ac-
ceptance of their treatment. Work demands were
classi® ed into three groups:
(1) a job requiring heavy physical activity was
de® ned as requiring the majority of time stand-
ing or walking with performance of strenuous
activities, e.g. lifting, climbing;
(2) domestic work that also required spending a
large proportion of time standing but did not
require strenuous physical activities;
(3) a non-physical occupation encompassed jobs
requiring less than 50% total time standing or
walking, e.g. desk work.
Due to the small number of patients, descriptive
analysis was used for demographic and tumour-
related variables. Repeated measures analysis of
variance was used to analyze functional status as
measured by the MSTS.
Results
Limb-salvage group
Patient characteristics. Twenty-nine patients under-
went limb-salvage surgery, with one patient having
bilateral extensive ® bromatosis and requiring
surgery on each foot. Sixteen patients were females
and 13 patients were males, with a mean age of 51
years (range 15± 78, SD 5 18.5). Mean follow-up
was 52 months (range 24± 109, SD 5 23.2).
At the time of presentation, 20 patients (67%)
had undergone either an excisional biopsy or had a
local recurrence. Only three patients (10%) were de
novo presentations, of which two were ® bromatosis
and the remaining seven were seen following inci-
sional biopsy performed elsewhere. In the majority
of patients referred following an excisional biopsy
the diagnosis of STS was unsuspected at the time of
initial surgery.
Two patients were treated with chemotherapy
prior to referral to the multi-disciplinary sarcoma
group. One patient had an embryonal rhabdomyo-
sarcoma with metastatic disease at presentation and
underwent thoracotomy following chemotherapy.
She was free of systemic disease 2 years later and
underwent limb salvage with curative intent. She
remains alive with no evidence of disease (ANED)
85 months after limb salvage. The second patient
received one course of chemotherapy prior to refer-
ral but locally progressed.
Tumour characteristics. There were 19 high-grade
sarcomas, ® ve low-grade sarcomas and six
® bromatoses. Histological types are shown in Table
1, with malignant ® brous histiocytoma (MFH) most
frequent in our series (23%), followed by
® brosarcoma in four patients (13%). Synovial sar-
coma was seen in only one of the limb-salvage70 N. R. Colterjohn et al.
patients. The mean tumour size was 6.4 cm and 17
of the lesions (57%) were greater than 5 cm in
maximum diameter. Four lesions were larger than
10 cm comprising two ® bromatoses, an MFH and a
sclerosing liposarcoma.
Thirteen of the lesions were situated around the
ankle, nine tumours were located on the dorsum of
the foot and seven lesions were on the plantar aspect
of the foot; one sarcoma involved the great toe. Four
of the ® bromatoses were on the plantar aspect of the
foot with the remaining two involving the lateral
ankle. Lesions were classi® ed as sub-fascial if they
were initially subcutaneous but at time of presen-
tation had gross sub-fascial disease or de® nite evi-
dence of sub-fascial extension from previous
surgery. Twenty-eight (93%) of the lesions were
sub-fascial at time of presentation and seventeen
were invasive, with direct involvement of bone (pre-
sent in 10 cases), nerve or vessel (present in nine
cases).
Limb-salvage procedure and adjuvant radiotherapy.
Limb salvage was performed by en bloc surgery with
removal of a cuff of normal tissue around the lesion
in 29 cases. In one case of ® bromatosis, an intrale-
sional resection was performed. The mean resection
specimen size was 11.3 cm and bone resection was
required in 10 patients. Reconstruction with a struc-
tural bone graft was carried out in three patients.
Dorsalis pedis or posterior tibialis vessel resection
was performed in seven patients and the super® cial
peroneal nerve was sacri® ced in four. Free muscle
¯ ap reconstruction utilized the rectus in ® ve pa-
tients, the latissimus dorsi in two patients and the
gracilis in one. Split thickness skin graft (STSG)
alone was used in seven patients.
Twenty-® ve patients received adjuvant radiother-
apy consisting of pre-operative treatment in eight
patients, pre-operative plus post-operative boost in
® ve cases, and post-operative treatment only in 12
cases. In the eight patients treated with free ¯ ap
reconstructions, adjuvant radiotherapy was used
pre-operatively in two patients, pre-operatively plus
post-operative boost in three patients, and post-
operatively only in three. Twenty-six patients had
negative microscopic margins, of whom 21 patients
received adjuvant radiotherapy. Each of the three
patients with microscopically positive resection mar-
gins and the one patient with ® bromatosis treated by
intralesional surgery received adjuvant radiotherapy.
Post-operative complications. Post-operative compli-
cations comprised four major wound problems, two
minor wound infections and one pulmonary embo-
lus. The four major wound infections required de-
bridement and healed by secondary intention. One
of these was in a patient with a foot lesion who
received post-operative radiotherapy to an STSG
which became secondarily infected.
Five patients suffered fractures within the high-
dose irradiation ® eld 4± 19 months following
surgery. Three of these patients had required partial
bone resection. There were two patients requiring
partial resections of the anterior tibia with ankle
arthrodesis, one with resection of the anterior talus,
and one patient who underwent partial resection of
the ® bula en bloc with the tumour. The ® fth patient
with a fracture had a drill hole passed through the
® rst metatarsal as part of her reconstructive pro-
cedure. The fractures healed in all but one patient
who suffered a fracture through the anterior tibial
bony defect. This patient went on to chronic non-
union despite bone grafting and ultimately required
below-knee amputation.
Functional outcome. Complete functional results
were available on 27 of the 30 consecutive cases
(90%) that underwent limb-salvage surgery (Table
2). The remaining three patients do not live close
to our centre and are followed near their home.
Measurements of the MSTS functional rating scale
at 3, 6, 12 months and most recent follow-up show
a gradual improvement in the functional score up to
12 months and a plateau beyond one year. This
® nding was not statistically signi® cant (overall
F-test, p 5 0.19). Fifteen patients were rated excel-
lent, eight good, and four fair or poor, at most
recent follow-up. Only two patients showed a de-
terioration of limb function over time. One patient
treated by surgery and irradiation to 66 Gy devel-
oped recreational restrictions and moderate pain
one year following treatment. The second patient
required amputation for complications of limb-
salvage. At the most recent visit, all but four patients
were enthusiastic about their limb-salvage result,
except four who reported being satis® ed with the
result.
Six patients were unable to return to their pre-
morbid employment. Three of six patients previ-
ously employed as labourers were unable to return
to work. This contrasts with the less physically-
demanding occupations in which 88% were able
to return to their premorbid level of activity. No
patients remaining off work at one year after surgery
were able to return to their original employment.
After one year, no patient had an improvement in
their overall functional rating, or improvement in
the clinical measurements of the MSTS functional
evaluation (motion, stability, deformity and
strength). Two patients, however, reported an im-
provement in their functional activity at most recent
follow-up which may suggest an adaptation to physi-
cal disability. Only three patients required an ambu-
latory aid at most recent assessment compared to
nine patients at 3 months after surgery. Two pa-
tients continue to use an orthosis, and two use a
rocker bottom sole on their footwear.
At 3 months after limb-salvage surgery, 56% of
patients had some degree of lower limb oedema.
At most recent assessment, six patients (22%)Limb-salvage surgery 71
Table 2. Functional status at 3, 6, 12 months, and most recent follow-up (n 5 27, missing 5 3)
Status 3 months 6 months 12 months Most recent
MSTS
Mean 27.45 29.93 31.42 31.00
SD 8.16 6.82 4.64 5.69
Range 11± 35 13± 35 17± 35 13± 35
Work status*
Labourer 0/6 1/6 2/6 3/6
Domestic 4/5 4/5 4/5 4/5
Non-physical 13/16 14/16 14/16 14/16
Requiring gait aid
None 18 21 22 24
Cane 5 3 4 2
Crutches 3 3 1 1
Walker 1 0 0 0
Persisting oedema**
None 12 16 16 21
Mild 8 8 9 5
Moderate 6 2 2 1
Severe 1 1 0 0
*Able to return to premorbid work.
**Criteria as per Stern.
25
continued to have mild leg oedema (Table 2).
Thirteen patients reported persistent pain, with the
majority having mild pain without need for narcotic
agents but two patients continued to require oc-
casional narcotic use for severe pain.
Oncologic outcome. At mean follow-up of 52
months (24± 109 months), there were four systemic
recurrences in patients with high-grade tumours,
one local recurrence in a patient with ® bromatosis
and one regional recurrence in a second patient with
® bromatosis (Table 3). The single patient experi-
encing local recurrence had undergone limb salvage
for a small (, 5 cm), de novo symptomatic
® bromatosis on the plantar aspect of the foot. The
lesion was resected with wide margins and no adju-
vant radiotherapy was used; recurrent ® bromatosis
developed 14 months after treatment. This patient
has had no further intervention and clinically is
stable with a good functional result. The patient
who developed regional recurrence had undergone
below-knee amputation for complications of limb
salvage and subsequently developed recurrence in
her stump. This recurrence was far removed from
the original lesion and more than 10 cm outside the
radiation ® eld used 3 years before. She is currently
disease free following above-knee amputation and
functioning with a prosthesis. Three patients are
dead of disease and one patient is alive with pul-
monary metastasis. All four patients had high-grade
lesions and developed systemic recurrence less than
one year following surgery (mean 7 months). Three
of the lesions showed invasive properties, either
encasing neurovascular structures or eroding into
adjacent bone. In total, 24 (80%) patients remain
disease free and 25 patients are currently alive with
no evidence of disease.
Amputation group
Six patients (four males and two females) with a
mean age of 52 years had below-knee amputations
for local disease; they had no metastatic disease
on pre-operative staging. Four patients were pre-
operatively considered unresectable due to the ex-
tensive involvement of local vital structures, while
the other two were found at the time of surgery to
be unresectable and underwent amputation shortly
thereafter. This group consisted of ® ve high-grade
lesions and one low-grade STS (Table 1). Two
sarcomas presented de novo, one following incisional
biopsy, and three after attempted excisional biopsy
and tumour contamination throughout the foot.
Three lesions originated around the ankle, two le-
sions involved the dorsal foot and one was situated
on the plantar aspect of the foot. With a mean
follow-up time of 26 months for the amputated
patients, three continue to be disease free. Two
patients are dead of disease and a third is alive with
systemic disease.
Table 3. Oncologic outcome in limb-salvage cases (n 5 30)
and patients with below-knee amputation (n 5 6)
Limb salvage Amputation
Outcome (%) (%)
Dead of disease 3 (10) 2 (33)
Alive, with evidence of
disease 1 1
Local recurrence 1 Ð
Regional recurrence 1* Ð
Disease-free survival 24 (80) 3 (50)**
*One patient developed recurrent ® bromatosis proximal
to the stump, following below-knee amputation for compli-
cation of limb salvage.
**One patient lost to follow-up 14 months post-
amputation.72 N. R. Colterjohn et al.
Discussion
STS sarcoma of the foot and ankle poses a dif® cult
challenge for limb preservation. With the success of
combined modality therapy in proximal extremity
STS, similar principles are being applied to achieve
limb salvage of the distal lower limb.
7,9,13,18,27 This
paper presents 36 consecutive cases of STS or ag-
gressive ® bromatosis treated by multi-modality ther-
apy by our sarcoma group. Patients with aggressive
® bromatosis requiring resection were included in
the study since the treatment of this disease often
requires combined management with both surgery
and adjuvant radiotherapy. Since the therapeutic
approach to both STS and ® bromatosis was similar
in our hands, we grouped these patients together in
order to gain a better understanding of the func-
tional results of treatment. Thirty cases underwent
limb salvage (83%) employing a consistently applied
protocol of wide local en bloc resection plus adjuvant
radiotherapy to supplement close surgical margins.
Since the ultimate goal in these patients is overall
survival and preservation of maximum limb func-
tion, a concurrent analysis of both outcomes is
appropriate.
Sugarbaker et al.,
20 in a landmark paper on quality
of life and functional assessment, did not substan-
tiate an improved function in limb salvage versus
amputation for STS of the upper and lower ex-
tremity. Patients were randomized to amputation or
limb salvage, with quality of life assessment at one
point in time. In their paper, Sugarbaker et al.
questioned the results of the study due to the gener-
alizability and sensitivity of the outcomes adminis-
tered. Currently, when possible, limb preservation is
preferred over amputation, even in the absence of
sound evidence in the literature.
7,9,13,18,27,28 This
study provides objective results on the functional
bene® t of limb-salvage surgery in patients with
localized soft tissue tumours of the foot and ankle.
While the MSTS
26 does not meet the current
standards of evaluating function from the patient’s
perspective,
29 we chose to evaluate function for this
study using the MSTS, 1987 version, as it was the
only measure available speci® c to the tumour limb-
salvage population at the time that prospective func-
tional data collection was begun. While it is
recognized that the MSTS includes many items
related to clinical parameters, e.g. range of motion,
strength, joint stability and joint deformity, this
scale does provide data that can be compared to
other published studies. Furthermore, we have
added an evaluation of work status in relation to job
demands as an indicator of function.
Eighty-® ve per cent of the patients had a good or
excellent functional outcome at most recent visit.
Sixteen patients had no functional limitations and
all patients were satis® ed with the result of their
treatment. The only exception was the patient who
required amputation for complication of treatment.
Fifty-two per cent had no pain and only two patients
required occasional narcotic use. The MSTS func-
tional evaluation rating scale showed a progressive
improvement in function with time and a plateau of
function after one year. This correlates with the
® nding that patients returned to work up to one year
following treatment but not beyond that time. This
information has implications with respect to patient
and physician expectations over time and the plan-
ning of post-operative physiotherapy.
Chou and Malawer
13 reviewed 33 patients with an
assortment of bone or soft tissue lesions of the foot
and ankle. Surgical management varied from simple
curettage to amputation. They reported that 82% of
patients had a good to excellent functional outcome
according to the MSTS functional evaluation cri-
teria and 55% were able to bear full weight and had
unlimited activity.
14 Supporting documentation was
not provided and it is not certain whether any
patients received radiotherapy. Nonetheless, their
population was con® ned to the foot and ankle and
provides one of the few papers in which a compari-
son of the functional outcome can be made with our
study.
Owens et al., in a retrospective study of 50 pa-
tients with stage M0 STS of the hand and foot,
emphasized that while local recurrence had an omi-
nous effect on prognosis, an improvement in local
control did not translate into an improved survival.
Approximately half of their patients had amputation
and the remainder had various combinations of
combined modality limb salvage.
7 A 5-year survival
of 68% with either amputation (no local recurrence)
or conservative surgery (32% local recurrence) was
reported, a ® nding shared by other authors.
2± 4,7,17,28
In our group of limb-salvage patients, no sarcoma
recurred locally although there was one local and
one regional recurrence of ® bromatosis (7%). There
was a 20% systemic recurrence rate at a mean time
of 7 months from presentation in patients with STS.
Heise et al., in an extensive review of extremity STS,
showed a median time to recurrence of 9.7 months
for local and systemic recurrence combined.
30 The
presence of occult metastatic disease at time of
presentation continues to be a challenge, especially
since no therapeutic interventions have thus far been
shown to improve prognosis.
31
Talbert et al. reported on 78 patients with con-
servative surgery and irradiation of the hand and
foot.
18 Nine patients had de® nite residual gross dis-
ease and no further surgery, while 46 patients with
piecemeal or simple local excision had no further
surgery. All patients were treated with a combi-
nation of adjuvant radiotherapy and chemotherapy.
There was a 19% local recurrence rate and the
complication rate was 56% in the lower extremity
versus 28% in the upper extremity. Thirteen per
cent of the lower extremity cases required ampu-
tation for complication of their treatment. Fifty-
three per cent of the distal lower extremity patientsLimb-salvage surgery 73
had normal function or mild to moderate functional
limitation. The use of radiotherapy to control local
disease when there is histological or gross evidence
of residual disease may not be prudent and the
larger dose required may lead to increased func-
tional morbidity.
2,5,7,8,31
Stinson et al. described both the frequent long-
term functional complications of radiotherapy and
methods to reduce their incidence.
33 They reported
a third of their patients had a moderate to severe
decrease in range of motion and a 19% rate of
oedema greater than 2 1 . Twenty-two per cent of
our patients had mild (1 1 ) or moderate (2 1 )
oedema using the criteria of Stern
25 at last visit.
Except in two patients, delayed local toxic effects of
adjuvant radiotherapy did not translate into a de-
terioration of function with time as shown in other
studies.
18,32,34 One patient had increasing pain in the
foot one year following radiotherapy. The second
patient required amputation for pathological frac-
ture and non-union 2 years after limb salvage. Im-
provement in radiotherapy technique has enabled
more accurate dosage to speci® c anatomical regions,
the sparing of part of the limb circumference and
the use of a more standardized, better tolerated
dose, reducing the risk of complications following
irradiation.
5,23
The combination of poor soft tissue coverage
following resection in a distal extremity that also
receives adjuvant radiotherapy can represent a major
challenge to the reconstructive surgeon. The use of
vascularized tissue transfer from distant sites brings
both soft tissue coverage and new blood supply to
the area. A review of wound healing complications
after extremity STS surgery and adjuvant radiother-
apy by Peat et al. showed an 11% major wound
complication rate with the use of vascularized tissue
transfers versus a 30% rate of complications with
direct wound closure.
23 In our series, two of eight
tissue transfers had major problems but only one
was not salvageable. Six of the vascularized ¯ aps
received post-operative radiotherapy of which one
developed partial ¯ ap necrosis. The residual ¯ ap
survived but the patient ultimately required ampu-
tation for a pathological fracture and non-union.
The successful use of a vascularized tissue transfer
in seven out of eight otherwise unreconstructable
limb-salvage patients supports the bene® t of this
technique in limb preservation surgery of the foot
and ankle.
A pathological fracture in the high-dose ir-
radiation ® eld (as experienced by ® ve patients in this
series) presents potentially devastating conse-
quences for limb function as demonstrated by the
one patient who required below-knee amputation
for chronic non-union. The two patients with the
anterior tibia cortical defects were part of a series of
patients in whom it was demonstrated that open
segmental cortical defects with adjuvant irradiation
increase the risk for pathological fracture.
3,5 Our
current practice when treating such patients is to
stabilize prophylatically the weakened bone with an
intramedullary rod, plate or bone graft. These frac-
tures may have been prevented using our current
management protocol.
Most published studies reporting outcome in foot
and ankle sarcoma have concentrated on oncologic
outcome with only a minor emphasis on functional
issues. The modi® ed MSTS functional evaluation
rating scale provides a means of assessing function
in the extremity. Combined with the excellent local
control achieved in this study the functional results
provide support for limb salvage as a primary goal in
the management of selected patients with STS of
the foot and ankle. Concurrent measurement of
function and oncologic outcome will better enable
us to assess future treatment interventions in the
management of STS of the extremities.
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